These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5236015)

  • 21. [Effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride on the blood flow of the extremities, blood pressure and venous capacity in normotensive subjects].
    Ehringer H
    Arzneimittelforschung; 1966 Sep; 16(9):1165-9. PubMed ID: 6014736
    [No Abstract]   [Full Text] [Related]  

  • 22. [The central effective mechanism of antihypertensive agents].
    Karppanen H
    Duodecim; 1974; 90(13):954-7. PubMed ID: 4411126
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
    Krämer D; Krause W; Renner H
    Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
    [No Abstract]   [Full Text] [Related]  

  • 24. [Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance].
    Knobloch H; Moor H
    Arzneimittelforschung; 1966 Sep; 16(9):1169-74. PubMed ID: 6014737
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antihypertensive drug. Dual action lowers blood pressure more effectively].
    MMW Fortschr Med; 2001 May; 143(18):49. PubMed ID: 11387709
    [No Abstract]   [Full Text] [Related]  

  • 26. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
    Hoefke W; Kobinger W
    Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
    [No Abstract]   [Full Text] [Related]  

  • 30. Observations on the hypotensive action of "Catapres" (ST 155) in man.
    Barnett AJ; Cantor S
    Med J Aust; 1968 Jan; 1(3):87-91. PubMed ID: 4867515
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood circulation studies with 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
    Kobinger W; Walland A
    Arzneimittelforschung; 1967 Mar; 17(3):292-300. PubMed ID: 5631221
    [No Abstract]   [Full Text] [Related]  

  • 34. Losartan--a new antihypertensive.
    Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
    [No Abstract]   [Full Text] [Related]  

  • 35. New angiotensin-II blocker.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic cystamine treatment inhibits small artery remodelling in rats.
    Eftekhari A; Rahman A; Schaebel LH; Chen H; Rasmussen CV; Aalkjaer C; Buus CL; Mulvany MJ
    J Vasc Res; 2007; 44(6):471-82. PubMed ID: 17657163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controlled long-term study in senile hypertension].
    Bergener M; Mittelstaedt A
    Arzneimittelforschung; 1970 Oct; 20(10):1542-5. PubMed ID: 5536421
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of hypertension with clonidine].
    Siitonen L; Koskinen P; Vuorio S; Bäckman H
    Duodecim; 1970; 86(14):818-25. PubMed ID: 5447795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
    Grabner G; Michalek P; Pokorny D; Vormittag E
    Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
    [No Abstract]   [Full Text] [Related]  

  • 40. [Imidazoline receptor agonists in the practical treatment of hypertension].
    Ol'binskaia LI; Bochenkov IuV; Alekseeva IL
    Ter Arkh; 1998; 70(2):86-8. PubMed ID: 9551585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.